Lam Research Corp. <LRCX.O>: BofA Global Research cuts price objective to $385.00 from $480.00
LRCX•Related News
Disc Medicine publishes corporate presentation on hematology pipeline targeting heme, iron pathways
IRON•
PennDOT partners with Liquidity Services’ GovDeals for statewide online auction of 350 surplus assets
LQDT•
Lucid Diagnostics schedules business update call to discuss Q2 2026 results
LUCD•
Seanergy Q2 FY26 net income swings to USD 26.2 million; revenue rises 48.6% to USD 55.7 million
SHIP•
Johnson & Johnson's Rybrevant Faspro™ (Amivantamab and Hyaluronidase-Lpuj) receives U.S. FDA priority review as potential first-in-class Egfr- and Met-targeted subcutaneous treatment for advanced head and neck cancer
JNJ•